FDA NDC Directory · JSON-LD · Markdown

Aprepitant

NDC 0781-2322 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameaprepitant
Labeler / ManufacturerSandoz Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA090999
Dosage form / routeCAPSULE · ORAL
Active ingredientsAPREPITANT (80 mg/1)
Marketing started20161227
Package count2

External sources

Source: openFDA. Public-domain (CC0).